The impact of pegylated recombinant human growth hormone replacement therapy on glucose and lipid metabolism in children with growth hormone deficiency | Zendy

AI Assistant Blog Pricing

The impact of pegylated recombinant human growth hormone replacement therapy on glucose and lipid metabolism in children with growth hormone deficiency

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.